- Home
- ENB vs BMY Comparison
ENB vs BMY Comparison
Compare ENB & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENB | BMY |
|---|---|---|
| Founded | 1949 | 1887 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.6B | 95.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ENB | BMY |
|---|---|---|
| Price | $47.09 | $51.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 12 |
| Target Price | ★ $63.00 | $55.58 |
| AVG Volume (30 Days) | 4.6M | ★ 15.2M |
| Earning Date | 11-07-2025 | 10-30-2025 |
| Dividend Yield | ★ 5.67% | 4.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.84 | ★ 2.97 |
| Revenue | $46,115,630,085.00 | ★ $48,034,000,000.00 |
| Revenue This Year | $15.33 | $0.23 |
| Revenue Next Year | $0.16 | N/A |
| P/E Ratio | $25.91 | ★ $17.05 |
| Revenue Growth | ★ 32.29 | 1.26 |
| 52 Week Low | $39.73 | $42.52 |
| 52 Week High | $50.54 | $63.33 |
Technical Indicators
Market Signals| Indicator | ENB | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 41.96 | 64.79 |
| Support Level | $47.70 | $48.22 |
| Resistance Level | $48.64 | $52.51 |
| Average True Range (ATR) | 0.74 | 1.14 |
| MACD | -0.09 | 0.23 |
| Stochastic Oscillator | 6.24 | 85.23 |
Price Performance
Historical ComparisonAbout ENB Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the US and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates regulated natural gas utilities in the US and Canada, including Canada's largest natural gas distribution company. The firm has a small renewable energy portfolio primarily focused on onshore and offshore wind projects.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.